- Filed
- Jun 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2027 · Jun 4, 2026 | 7.75M sh |
| Shares Diluted | Q1 2027 · Apr 30, 2026 | 7.77M sh |
| Shares Diluted | Q1 2027 · Apr 30, 2025 | 7.56M sh |
| Capex | Q1 2027 · Apr 30, 2026 | $36K |
| Capex | Q1 2027 · Apr 30, 2025 | $60K |
| Operating Cash Flow | Q1 2027 · Apr 30, 2026 | $3.02M |
| Operating Cash Flow | Q1 2027 · Apr 30, 2025 | $4.4M |
| Long Term Debt | Q1 2027 · Apr 30, 2026 | $16.23M |
| Long Term Debt | Q1 2027 · Jan 31, 2026 | $18.3M |
| Cash And Equivalents | Q1 2027 · Apr 30, 2026 | $4.68M |
| Cash And Equivalents | Q1 2027 · Jan 31, 2026 | $4.07M |
| Stockholders Equity | Q1 2027 · Apr 30, 2026 | $77.52M |
| Stockholders Equity | Q1 2027 · Jan 31, 2026 | $76.86M |
| Stockholders Equity | Q1 2027 · Apr 30, 2025 | $76.55M |
| Stockholders Equity | Q1 2027 · Jan 31, 2025 | $75.75M |
| Current Liabilities | Q1 2027 · Apr 30, 2026 | $42.36M |
| Current Liabilities | Q1 2027 · Jan 31, 2026 | $38.37M |
| Total Liabilities | Q1 2027 · Apr 30, 2026 | $62.33M |
| Total Liabilities | Q1 2027 · Jan 31, 2026 | $60.7M |
| Current Assets | Q1 2027 · Apr 30, 2026 | $74.65M |
| Current Assets | Q1 2027 · Jan 31, 2026 | $70.7M |
| Total Assets | Q1 2027 · Apr 30, 2026 | $139.86M |
| Total Assets | Q1 2027 · Jan 31, 2026 | $137.57M |
| Eps Diluted | Q1 2027 · Apr 30, 2026 | $0.08 |
| Eps Diluted | Q1 2027 · Apr 30, 2025 | −$0.05 |
| Eps Basic | Q1 2027 · Apr 30, 2026 | $0.09 |
| Eps Basic | Q1 2027 · Apr 30, 2025 | −$0.05 |
| Sga Expense | Q1 2027 · Apr 30, 2026 | $5.36M |
| Sga Expense restated | Q1 2027 · Apr 30, 2025 | $4.25M |
| Rd Expense | Q1 2027 · Apr 30, 2026 | $1.81M |
| Rd Expense restated | Q1 2027 · Apr 30, 2025 | $1.53M |
| Net Income | Q1 2027 · Apr 30, 2026 | $653K |
| Net Income | Q1 2027 · Apr 30, 2025 | −$376K |
| Operating Income | Q1 2027 · Apr 30, 2026 | $1.56M |
| Operating Income | Q1 2027 · Apr 30, 2025 | $571K |
| Gross Profit | Q1 2027 · Apr 30, 2026 | $14.43M |
| Gross Profit restated | Q1 2027 · Apr 30, 2025 | $11.95M |
| Cost Of Revenue | Q1 2027 · Apr 30, 2026 | $24.94M |
| Cost Of Revenue restated | Q1 2027 · Apr 30, 2025 | $25.76M |
| Revenue | Q1 2027 · Apr 30, 2026 | $39.36M |
| Revenue | Q1 2027 · Apr 30, 2025 | $37.71M |